Correction: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Hariani, Gunjan D ^a   Lam, Ernest T ^b   Havener, Tammy ^c   Kwok, Pui Yan ^b   McLeod, Howard L ^c,d   Wagner, Michael J ^c   Motsinger Reif, Alison A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of North Carolina   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84908152746     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-652     Document Type: Erratum

References (1)

1. Hariani GD, Lam EJ, Havener T, Kwok PY, McLeod HL, Wagner MJ, Motsinger-Reif AA: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics. BMC Res Notes 2014, 7:360.